Quanta BioSciences is a leading brand that specializes in providing advanced DNA and RNA amplification reagents for molecular testing applications in various fields, including applied, translational, and life science research. With decades of experience, their team has developed cutting-edge amplification technologies to deliver innovative products for critical cloning, PCR, qPCR, and Next-Generation Sequencing (NGS) applications. Located in Beverly, Massachusetts, Quanta BioSciences offers a wide range of products through their international sales operations, along with a global network of distributors and commercial service providers.

Their reagent technologies are engineered for stability, ensuring enzyme activation control with AccuStart technology and enabling reaction setup and multi-day storage at ambient temperature. The products are made with ultrapure enzymes, with ultralow residual host E. Quanta BioSciences' reagents are formulated specifically for quantitative real-time PCR, with optimized 1-tube reagents to minimize pipetting steps and improve accuracy.

The products eliminate error-causing persistent bubbles and support efficient vortex mixing, and their AccuVue plate-loading dye provides visual confirmation of reaction assembly. Their ToughMix reagents are designed to withstand a broad spectrum of PCR inhibitors, overcoming challenging starting materials and crude extracts with reliable assay performance. The products are also optimized to improve sequencing performance and economics, offering comprehensive solutions for DNA fragmentation, library preparation, amplification, and quantification.

Their novel formulations streamline NGS workflows, reducing turnaround time, and proprietary enzymes and buffer compositions enhance library yields and sequencing results from low inputs. With a legacy of innovation, Quanta BioSciences has a rich history of creating market-leading PCR and qPCR reagents. Over the years, they have developed a range of revolutionary products that have become industry standards.

In recent years, they have expanded their product portfolio to include solutions for cloning and NGS, complementing their existing molecular biology portfolios for sample prep, cDNA synthesis, PCR, and qPCR. From their founding in 2001 as Quanta Biosciences to their renaming as Quantabio in 2016, the brand has consistently pushed the boundaries of scientific research. They have introduced numerous groundbreaking products, including the PerfeCTa SuperMix, accuStart II Taq DNA Polymerase, and sparQ HiFi PCR Master Mix, among others.

Their dedication to innovation continues with the development of high-quality extraction kits, the next generation of cDNA synthesis products, and the expansion of their NGS product portfolio. With their commitment to excellence and a wide range of high-performance products, Quantabio is poised to meet the evolving needs of researchers worldwide, empowering them to achieve groundbreaking discoveries in the field of molecular testing